Evidence map›Paper›PMID 34778010›Full record

ArticlePublic health action2021

High antibiotic resistance and mortality with

M Mahto, M Chaudhary, A Shah, K L Show, F L Moses, A G Stewart

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health action, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Assessment of Antibiotic Resistance among Clinical Isolates of Enterobacteriaceae in Nepal.The American journal of tropical medicine and hygiene · 2024
    Article
  3. Carbapenem Resistance inBioMed research international · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

M MahtoNepal Mediciti Hospital, Bhainsepati, Lalitpur, Nepal.
M ChaudharyNepal Mediciti Hospital, Bhainsepati, Lalitpur, Nepal.
A ShahKist Medical College and Teaching Hospital, Nepal.
K L ShowDepartment of Medical Research, Yangon, Myanmar.
F L MosesSierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone.
A G StewartCollege of Life and Environmental Science, University of Exeter, Exeter, UK.
KIST Medical College · NPMinistry of Health and Sanitation · SLMyanmar Oxford Clinical Research Unit · MMUniversity of Exeter · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

settingNepal Mediciti Hospital, Bhainsepati, Lalitpur, Nepal.

objectivesTo determine antimicrobial resistance patterns, and the number and proportion of multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) cases among all patients with

designThis was a hospital laboratory-based, cross-sectional study.

results

conclusionA significant proportion of MDR and XDR isolates was found; nearly one patient in five died. Robust hospital infection prevention and control measures (particularly for respiratory and invasive procedures) and routine surveillance are needed to reduce infections and decrease the mortality rate. Tigecycline, polymyxin B and colistin should be cautiously used only in MDR and XDR cases.

Indexed as

adverse outcomesextensively drug-resistantIraqibacterMDRmultidrug resistantoperational researchXDR

Identifiers

PMID34778010
PMCPMC8575387
OpenAlexW3213330860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.